Sedia

US-based healthcare firm Sedia Biosciences has launched the Asanté DNA specimen collection kit and the Asanté DNA purification kit.

The specimen collection kit is claimed to have low DNA retention, minimal interfering substances and ease of use, and is designed as a cost-competitive alternative to current methods.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

In order to facilitate extraction, purification and concentration of DNA from the kit, Sedia has also launched the purification kit.

The kit has been developed to collect oral DNA specimens with minimal downstream processing or extraneous reagent introduction, while maximising DNA yield.

"The Asante DNA kit has been developed to collect oral DNA specimens with minimal downstream processing."

Research investigators who evaluated the product during development found that it can be used to collect DNA from a variety of tissue types and locations, including genitourinary tract specimens, cadaverous samples, tissue speciation and identification, food pathogen testing, and other biological fluid characterisations.

Sedia Biosciences president and chief science officer Ronald Mink said: "Our Asanté DNA specimen collection kit is built upon our expertise in assay development, where we have identified low binding matrices that can be used to readily take up and release DNA, as well as other analytes.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

"This has reduced the need for abrasive materials, hazardous chemical reagents or extreme concentration methods used by other manufacturers to obtain adequate DNA samples and enabled us to produce a lower-cost DNA collection device."

Sedia Biosciences CEO Roger Gale said: "We are excited about our entry into the DNA collection device market, and optimistic that our product can compete internationally against other products that perform less effectively and cost more."

The device offers samples, which are suitable for testing by most in-vitro DNA amplification methods, including the polymerase chain reaction (PCR) and modifications, pretreatments and extensions, helicase-dependent amplification (HDA), ligase chain reaction (LCR), and the loop-mediated isothermal amplification (LAMP).


Image: The Asanté DNA Specimen Collection Kit from Sedia Biosciences. Photo: courtesy of Business Wire / Sedia Biosciences Corporation.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact